Immunocore Holdings plc
IMCR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001671927
No open-market purchases or sales by Immunocore Holdings plc insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $1.65B in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Immunocore Holdings plc changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 86 | 104 | +18 |
| Shares | 26.5M | 30.3M | +3.73M (+14.1%) |
| Value | $1.25B | $1.73B | +$480.2M (+38.5%) |
New holders (31)
Institutions that held Immunocore Holdings plc at the end of Q4 2022 but not at the end of Q3 2022.
Sold out (13)
Institutions that held Immunocore Holdings plc at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Rathbone Brothers plc | 190,015 | $8.92M |
| VR Adviser, LLC | 94,605 | $4.44M |
| Great Point Partners LLC | 78,527 | $3.69M |
| UBS Oconnor LLC | 34,697 | $1.63M |
| ETF Managers Group, LLC | 12,944 | $608.0K |
| Man Group plc | 8,900 | $418.0K |
| Vanguard Group Inc | 8,202 | $385.0K |
| Victory Capital Management Inc | 8,186 | $384.0K |
| Gsa Capital Partners LLP | 4,892 | $230.0K |
| Parallax Volatility Advisers, L.P. | 3,470 | $163.0K |
| Simplex Trading, LLC | 472 | $22.0K |
| Group One Trading, L.P. | 100 | $5.00K |
| Cullen/Frost Bankers, Inc. | 11 | $1.00K |